Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity ; volume:4 ; number:1 ; day:15 ; month:3 ; year:2024 ; pages:1-10 ; date:12.2024
Communications medicine ; 4, Heft 1 (15.3.2024), 1-10, 12.2024
- Urheber
-
Geanes, Eric S.
McLennan, Rebecca
LeMaster, Cas
Bradley, Todd
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s43856-024-00477-z
- URN
-
urn:nbn:de:101:1-2405172123590.138227650798
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Geanes, Eric S.
- McLennan, Rebecca
- LeMaster, Cas
- Bradley, Todd
- SpringerLink (Online service)
Ähnliche Objekte (12)
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
ACE2 polymorphisms impact COVID-19 severity in obese patients
Immune response profiling identifies autoantibodies specific to Moyamoya patients
Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus
Immune modulation by molecules of Staphylococcus aureus
Atopic dermatitis and autoimmunity: the occurrence of autoantibodies and their association with disease severity
Functional Characterization of ACE2 Regulation in SARS-CoV-2-Infection-Associated Immune Response
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
ACE2 polymorphisms impact COVID-19 severity in obese patients
Immune response profiling identifies autoantibodies specific to Moyamoya patients
Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus
Immune modulation by molecules of Staphylococcus aureus
Atopic dermatitis and autoimmunity: the occurrence of autoantibodies and their association with disease severity
Functional Characterization of ACE2 Regulation in SARS-CoV-2-Infection-Associated Immune Response
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
ACE2 polymorphisms impact COVID-19 severity in obese patients
Immune response profiling identifies autoantibodies specific to Moyamoya patients
Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus
Immune modulation by molecules of Staphylococcus aureus
Atopic dermatitis and autoimmunity: the occurrence of autoantibodies and their association with disease severity
Functional Characterization of ACE2 Regulation in SARS-CoV-2-Infection-Associated Immune Response
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity